The 3D Cell Bioprinting Consortium (traded on the EquityZen secondary marketplace under the symbol TDCC) is an alliance of laboratory-instrument and biomaterials companies formed in 2016 and publicly launched in February 2017, headquartered in Marlborough, Massachusetts. It describes itself as "a group of companies focused on offering the complete solution for tissue engineering" — coordinating bioprinter hardware, bioinks and hydrogels, cell lines and culture reagents into a single workflow for pre-clinical drug discovery, regenerative medicine and diagnostics. It was founded by Sid Braginsky, CEO and Chairman of Digilab Corp., and its named members include Digilab, Inc. (maker of the CellJet cell printer, represented by President and COO John Moore) and 3-D Matrix, Inc. (self-assembling peptide hydrogels, represented by Managing Director Marc Rioult). The consortium is a coordinating body for physical laboratory products, not a software vendor: it publishes no first-party website, developer portal, documentation, SDK, or machine-readable API specification, and no domain matching its name resolves in DNS. This profile is an independent third-party record; there is no API surface to enrich.
3D Cell Bioprinting Consortium is profiled on the APIs.io network. Tagged areas include Company, Consortium, Bioprinting, Tissue Engineering, and Life Sciences.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: 3dcellbioprintingconsortium
name: 3D Cell Bioprinting Consortium
description: 'The 3D Cell Bioprinting Consortium (traded on the EquityZen secondary marketplace under the symbol TDCC) is
an alliance of laboratory-instrument and biomaterials companies formed in 2016 and publicly launched in February 2017, headquartered
in Marlborough, Massachusetts. It describes itself as "a group of companies focused on offering the complete solution for
tissue engineering" — coordinating bioprinter hardware, bioinks and hydrogels, cell lines and culture reagents into a single
workflow for pre-clinical drug discovery, regenerative medicine and diagnostics. It was founded by Sid Braginsky, CEO and
Chairman of Digilab Corp., and its named members include Digilab, Inc. (maker of the CellJet cell printer, represented by
President and COO John Moore) and 3-D Matrix, Inc. (self-assembling peptide hydrogels, represented by Managing Director
Marc Rioult). The consortium is a coordinating body for physical laboratory products, not a software vendor: it publishes
no first-party website, developer portal, documentation, SDK, or machine-readable API specification, and no domain matching
its name resolves in DNS. This profile is an independent third-party record; there is no API surface to enrich.'
url: https://raw.githubusercontent.com/api-evangelist/3dcellbioprintingconsortium/refs/heads/main/apis.yml
x-harvest-source-url: https://equityzen.com/company/3dcellbioprintingconsortium/
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: no-api-surface
x-founded: '2016'
x-headquarters: Marlborough, Massachusetts, United States
x-domain-status: none
x-domain-note: No first-party domain was found. Six name-derived candidates were probed and every one is NXDOMAIN (3dcellbioprintingconsortium.com/.org,
3dcellbioprinting.com/.org, bioprintingconsortium.org, cellbioprintingconsortium.com). The only reachable record of the
company is the EquityZen secondary-market listing, which is a trading venue and NOT the company's web presence, so it is
recorded as x-harvest-source-url and is deliberately not wired as a Website pointer (roadmap#56). Note also that digilabglobal.com
— the former host of founding member Digilab, Inc. — has been re-registered and now serves an unrelated online-gambling
site, so it is not usable as a consortium surface either.
specificationVersion: '0.20'
created: '2026-09-05'
modified: '2026-09-05'
tags:
- Company
- Consortium
- Bioprinting
- Tissue Engineering
- Life Sciences
- Biotechnology
- Regenerative Medicine
- Laboratory Instruments
- Biomaterials
- Drug Discovery
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
x-coverage:
state: none
reason: not-a-software-company
detail: 'The consortium is a marketing and coordination alliance for bioprinter hardware, bioinks and cell-culture reagents
— physical laboratory products — and it publishes no web presence of its own at all: every name-derived domain is NXDOMAIN
and the only reachable record is its EquityZen secondary-market listing, so there is no host on which a developer program,
spec or /.well-known surface could exist.'
evidence:
- url: https://equityzen.com/company/3dcellbioprintingconsortium/
status: 200
- url: https://3dcellbioprintingconsortium.com/
status: 0
- url: https://3dcellbioprinting.com/
status: 0
- url: https://bioprintingconsortium.org/
status: 0
- url: https://www.crunchbase.com/organization/3d-cell-bioprinting-consortium
status: 403
- url: https://api.github.com/orgs/3dcellbioprintingconsortium
status: 404
checked: '2026-09-05'
x-enrichment:
date: '2026-09-05'
status: minimal
artifacts_added: 0
pass: local-v3
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.